2021年呼吸道感染病原诊断进展
综述总结2021年呼吸道感染病原诊断领域进展,指出超过50%患者未能明确致病微生物,临床宏基因组学与CRISPR等新技术提高检出率同时带来新挑战。
要点
- 呼吸道感染可由细菌、病毒、真菌等多种病原引起,快速准确检测是有效诊治关键。
- 超过50%患者因样本质量、前期抗菌治疗、病原多样及正常菌群影响未获病原诊断。
- 临床宏基因组学与CRISPR等新方法提升检出能力,但临床应用仍面临挑战。
核心结论
- 新型分子诊断技术提高呼吸道感染病原检出能力,但临床获益与挑战并存。
研究设计与样本
- 综述总结2021年呼吸道感染病原诊断领域进展,从临床视角讨论新方法的应用。
主要发现
- 超过50%的呼吸道感染患者未能诊断出明确致病微生物。
- 临床宏基因组学和CRISPR等新型检测技术取得迅速发展。
临床怎么用
- 临床应关注新型分子诊断工具在真实世界中的应用价值与局限。
局限性
- 综述指出新型检测方法在提高检出率的同时也带来新的挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Respiratory tract infections (RTI) are a common and highly prevalent disease in the population, which can develop into acute respiratory distress syndrome (ARDS) in severe cases.A large variety of microorganisms can cause RTI, including bacteria, respiratory viruses, and fungi. The timely and accurate detection of these pathogens is the prerequisites of effective treatment of RTI. However, more than 50% of RTI patients failed to diagnosis of causative agents due to unavailability of qualified samples, antimicrobial treatment prior to sample collection, high variety of respiratory pathogens, and influence of the normal flora in respiratory tract. In recent years, progress on molecular diagnosis, especially the novel approaches such as clinical metagenomics and CRSIPR (Clustered regularly interspaced short palindromic repeats), has not only improved our capacity for RTI pathogen detection but also brought new challenges. In this review, we summed up the advances in RTI pathogen diagnosis in 2021 and discussed the clinical benefits and challenges from novel approaches, which provided a clinical perspective on the development and application of these diagnostic tools in the real world. 呼吸道感染是人群的常见和高发疾病,严重时可发展为ARDS。各类病原微生物如细菌、真菌、病毒,均可引起呼吸道感染,快速准确的病原检测是实现呼吸道感染疾病有效诊治的关键,但超过50%的患者未能诊断出明确的致病微生物。近年来,以临床宏基因组学、CRISPR(成簇规律间隔的短回文重复序列)为代表的新型检测技术在病原诊断领域取得了迅速发展,在提高病原检出率的同时,也带来了新的挑战。本文综述了过去1年来呼吸道感染病原诊断领域的进展和成果,为呼吸道感染的病原诊断提供临床视角的思考。.
引用
- Zou XH, Cao B. [Advances in pathogen diagnosis of respiratory infection diseases in 2021]. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35000310. doi:10.3760/cma.j.cn112147-20211116-00809
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。